Amal Elhage

15PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)BiomechanicsHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 24, 2026
The P2X7 receptor: insights from the murine monoclonal antibody clone L4.

|May 29, 2026
Microencapsulated docosahexaenoic acid increases the Omega-3 Index and attenuates the physiological impact of eccentric exercise in physically trained adults: a 12-week double-blind placebo-controlled trial.

|Nov 10, 2025
Adeno-associated viral vectors encoding anti-P2X7 nanobodies reduce graft-versus-host disease in a humanised mouse model.

Amal Elhage, Janna H Hadaya, Chloe Sligar

|Oct 28, 2025
Low- and high-dose post-transplant cyclophosphamide attenuates graft-versus-host disease with distinct effects on PD-1+ T cell subsets.

Chloe Sligar, Miles J Jacobs, Amal Elhage

|Mar 18, 2025
Use of Human Chronic Myeloid Leukemia Cells to Study Graft-Versus-Leukemia Immunity in a Xenogeneic Mouse Model of Graft-Versus-Host Disease.

Chloe Sligar, Nicolas R Tomasiello, Peter Cuthbertson

|Mar 18, 2025
Humanized Mouse Model of Graft-Versus-Host Disease Utilizing Nonirradiated NOD-scid-IL-2Rγnull Mice.

Amal Elhage, Chloe Sligar, Debbie Watson

Pageof 3

Frequent Collaborators

15 joint publications

Ronald Sluyter

11 joint publications

Debbie Watson

11 joint publications

Chloe Sligar

6 joint publications

Peter Cuthbertson